Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0519 Transporter Info | ||||
| Gene Name | CACNA1B | ||||
| Transporter Name | Voltage-gated calcium channel alpha Cav2.2 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Mibefradil Drug Info | ||||
| Xenobiotic Type | Drug in Phase 1 Trial | ||||
| MOA | Inhibition | ||||
| PubChem CID | 60663 | ||||
| Docking Score | -9.773 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C29H38FN3O3 | ||||
| Molecular Weight | 495.6 | ||||
| Canonical SMILES |
CC(C)[C@H]1C2=C(CC[C@@]1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)COC)C=C(C=C2)F
|
||||
| InChI |
InChI=1S/C29H38FN3O3/c1-20(2)28-23-12-11-22(30)18-21(23)13-14-29(28,36-27(34)19-35-4)15-17-33(3)16-7-10-26-31-24-8-5-6-9-25(24)32-26/h5-6,8-9,11-12,18,20,28H,7,10,13-17,19H2,1-4H3,(H,31,32)/t28-,29-/m0/s1
|
||||
| InChIKey | HBNPJJILLOYFJU-VMPREFPWSA-N | ||||
| Pharmaceutical Properties | Xlogp | 5.8 | Rotatable Bond Count | 12 | |
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 6 | ||
| Xenobiotic Name | Miconazole Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 4189 | ||||
| Docking Score | -9.28 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C18H14Cl4N2O | ||||
| Molecular Weight | 416.1 | ||||
| Canonical SMILES |
C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
|
||||
| InChI |
InChI=1S/C18H14Cl4N2O/c19-13-2-1-12(16(21)7-13)10-25-18(9-24-6-5-23-11-24)15-4-3-14(20)8-17(15)22/h1-8,11,18H,9-10H2
|
||||
| InChIKey | BYBLEWFAAKGYCD-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 5.3 | Rotatable Bond Count | 6 | |
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 2 | ||
| Xenobiotic Name | GNF-PF-3464 Drug Info | ||||
| Xenobiotic Type | Investigative Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 666034 | ||||
| Docking Score | -8.91 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C19H16BrN3O2S | ||||
| Molecular Weight | 430.3 | ||||
| Canonical SMILES |
CC1=CC=C(O1)C2CC(=O)N3CN(CSC3=C2C#N)C4=CC=C(C=C4)Br
|
||||
| InChI |
InChI=1S/C19H16BrN3O2S/c1-12-2-7-17(25-12)15-8-18(24)23-10-22(11-26-19(23)16(15)9-21)14-5-3-13(20)4-6-14/h2-7,15H,8,10-11H2,1H3
|
||||
| InChIKey | DCNZODDMKOTPHQ-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 3.7 | Rotatable Bond Count | 2 | |
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 5 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.